· Hypertension

· Prophylaxis of stress angina attacks

· Long-term treatment after myocardial infarction (acebutolol decreases risk of recurrence, myocardial infarction and mortality, especially sudden death)

· Treatment of certain rhythm disorders: supraventricular (tachycardia, flutters and atrial fibrillations, tachycardia, junctional) or ventricular (ventricular extrasystolia, ventricular tachycardias). >
Hypertension: The usual daily dose of acebutolol is 400 mg, which is administered either as a single dose, every morning (400 mg dosage form), or in two doses, one The morning and evening. This dosage may be increased in case of hypertension, severe arterial disease

This dose may be increased in case of severe arterial hypertension

Prophylaxis of angina attacks, stress, tachyarrhythmias: The daily dose may range from 400 to 800 mg (600 mg on average), starting with the lowest dose and adapting gradually Dosage in the clinical state, or electrocardiogram.

Long-term treatment after myocardial infarction: treatment with acebutolol should preferably be instituted between the 3 rd and the 21 st day after the acute episode of infarction: the dosage is 2 tablets To 200 mg, per day, in two divided doses.
Film-coated tablet

BETA-BLOCKERS, SELECTIVE, Code, ATC: C07AB04.

(C: system, cardiovascular).

Acebutolol is characterized by three pharmacological properties

· Beta-blocking beta-1 activity, selective

· Antiarrhythmic effect

· Partial agonist potency (sympathomimetic activity, intrinsic moderate).

Not applicable.

This medicinal product MUST NEVER be used in the following cases

· Asthma and chronic obstructive pulmonary disease in their severe forms

· Cardiac insufficiency not controlled by the treatment.

· Cardiogenic shock.

· Atrioventricular blocks of the second and third degrees, not paired.

· Prinzmetal Angina (in pure and monotherapy forms).

· Sinus disease (including sino-atrial block).

· Bradycardia (